Fol. Biol. 2015, 61, 26-32
https://doi.org/10.14712/fb2015061010026
Antioxidant Status in Blood of Gynaecological Patients: Influence of Diagnosis and Reproductive Factors
References
1. 2008) Redox considerations in female reproductive function and assisted reproduction: from molecular mechanisms to health implications. Antioxid. Redox Signal. 10, 1375-1403.
< , A., Gupta, S., Sekhon, L., Shah R. (https://doi.org/10.1089/ars.2007.1964>
2. 2012) The effects of oxidative stress on female reproduction: a review. Reprod. Biol. Endocrinol. 10, 49.
< , A., Aponte-Mellado, A., Premkumar, B. J., Shaman, A., Gupta S. (https://doi.org/10.1186/1477-7827-10-49>
3. Beutler, E. (1982) Catalase. In: Red Cell Metabolism, a Manual of Biochemical Methods, ed. Beutler, E., pp. 105-106. Grune and Stratton, New York.
4. 1985) Inactivation of glutathione peroxidase by superoxide dismutase radical. Arch. Biochem. Biophys. 240, 500-508.
< , J., Fridovich, I. (https://doi.org/10.1016/0003-9861(85)90056-6>
5. 2005) Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors. Cancer Epidemiol. Biomarkers Prev. 14, 2929-2935.
< , L. A., Sakoda, L. C., Sherman, M. E., Frederiksen, K., Kjaer, S. K., Graubard, B. I., Olsen, J. H., Mellemkjaer, L. (https://doi.org/10.1158/1055-9965.EPI-05-0394>
6. 1999) Elevated lipid peroxidation and disturbed antioxidant enzyme activities in plasma and erythrocytes of patients with uterine cervicitis and myoma. Clin. Biochem. 32, 189-192.
< , J. F., Hu, M. L. (https://doi.org/10.1016/S0009-9120(98)00110-6>
7. 2004) Neoplasms of the reproductive tract: the role of hormone exposure. ILAR J. 45, 179-188.
< , J. M. (https://doi.org/10.1093/ilar.45.2.179>
8. Cook, L. S., Weiss, N. S., Doherty, J. A. Chen, C. (2006) Endometrial cancer. In: Cancer Epidemiology and Prevention, eds. Schottenfeld, D., Fraumeni J. F. Jr., pp. 1027- 1044. Oxford University Press, New York.
9. 2006) Biomarkers of oxidative damage in human disease. Clin. Chem. 52, 601-623.
< , I., Rossi, R., Colombo, R., Giustarini, D., Milzani, A. (https://doi.org/10.1373/clinchem.2005.061408>
10. 2007) Tumor necrosis factor-α and oxidant status are essential participating factors in unexplained recurrent spontaneous abortions. Clin. Chem. Lab. Med. 45, 879-883.
< , M., El-Sayed, I. H., El-Motwally, Ael G., Hashem, I. A., Bakry, N. (https://doi.org/10.1515/CCLM.2007.138>
11. 2008) Risk of complex and atypical endometrial hyperplasia in relation to anthropometric measures and reproductive history. Am. J. Epidemiol. 168, 563-570.
< , M., Reed, S. D., Voigt, L. F., Newton, K. M., Holt, V. L. Weiss, N. S. (https://doi.org/10.1093/aje/kwn168>
12. 2004). Managing woman with the post-menopausal bleeding. Best Pract. Res. Clin. Obstet. Gynaecol. 18, 125-143.
< , E., Valentin, L. (https://doi.org/10.1016/j.bpobgyn.2003.10.001>
13. 1999) An evaluation of risk factors for endometrial hyperplasia in premenopausal women with abnormal menstrual bleeding. Am. J. Obstet. Gynecol. 181, 525-529.
< , C. M., Lethaby, A., Sowter, M., Verry, J. Baranyai, J. (https://doi.org/10.1016/S0002-9378(99)70487-4>
14. 2003) Can ultrasound replace dilation and curettage? A longitudinal evaluation of postmenopausal bleeding and transvaginal sonographic measurement of the endometrium as predictors of endometrial cancer. Am. J. Obstet. Gynecol. 188, 401-408.
< , B., Karlsson, B., Milsom, I., Granberg, S. (https://doi.org/10.1067/mob.2003.154>
15. 2006) Reactive species and antioxidants. Redox biology is a fundamental theme of aerobic life. Plant Physiol. 141, 312-322.
< , B. (https://doi.org/10.1104/pp.106.077073>
16. 2001) Superoxide dismutase: an emerging target for cancer therapeutics. Expert Opin. Ther. Targets 5, 697-710.
< , E. A., Achanta, G., Huang, P. (https://doi.org/10.1517/14728222.5.6.697>
17. 2000) Antioxidants: their role in pregnancy and miscarriage. Antiox. Redox Signal. 2, 623-628.
< , C., Wilson, R., Roberts, J., Miller, H., McKillop, J. H., Walker, J. J. (https://doi.org/10.1089/15230860050192369>
18. 1995) Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding – a Nordic multicenter study. Am. J. Obstet. Gynecol. 172, 1488-1494.
< , B., Granberg, S., Wikland, M., Ylostalo, P., Torvid, K., Marsal, K., Valentin, L. (https://doi.org/10.1016/0002-9378(95)90483-2>
19. 2001). The antioxidant-prooxidant balance in pregnancy complicated by spontaneous abortion. Ginekol. Pol. 72, 1073-1078. (in Polish)
, L., Paszkowski, T., Sikorski, R., Rola, R. (
20. 1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
< , O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J. (https://doi.org/10.1016/S0021-9258(19)52451-6>
21. 2004) Enhanced lipid peroxidation and impaired enzymic antioxidant activities in the erythrocytes of patients with cervical carcinoma. Cell. Mol. Biol. Lett. 9, 699-707.
, S., Kolanjiappan, K., Kayalvizni, M. (
22. 1997) Direct evidence for catalase as the predominant H2O2-removing enzyme in human erythrocytes. Blood 90, 4973-4978.
< , S., Riedel, H. D., Stremmel, W. (https://doi.org/10.1182/blood.V90.12.4973>
23. 1995) Body mass index, weight gain, and risk of endometrial cancer. Nutr. Cancer 23, 141-149.
< , S. H., Trevisan, M., Marshall, J. R., Graham, S., Zielezny, M., Vena, J. E., Hellmann, R., Freudenheim, J. L. (https://doi.org/10.1080/01635589509514370>
24. 2008) Role of glutathione S-transferase polymorphisms and chronic allograft dysfunction. Transplant. Proc. 40, 743-745.
< , R. G., Abbud-Filho, M., Alvarenga M. P. S., Ferreira- Baptista M. A. S., Biselli J. M., Biselli P. M. Goloni- Bertollo E. M., Pavarino-Bertelli, E. C. (https://doi.org/10.1016/j.transproceed.2008.03.008>
25. 2000) Risk factors among young women with endometrial cancer: a Danish casecontrol study. Am. J. Obstet. Gynecol. 182, 23-29.
< , M., Lidegaard, Ø., Klintorp, S., Pedersen, B., Jønsson, L., Eriksen, P. S., Ottesen, B. (https://doi.org/10.1016/S0002-9378(00)70486-8>
26. 2006) Lipid peroxidation and antioxidant status in blood of patients with uterine myoma, endometrial polypus, hyperplastic and malignant endometrium. Biol. Res. 39, 619-629.
< , S., Kasapović, J., Todorović, A., Stojiljković, V., Pajović, S. B. (https://doi.org/10.4067/S0716-97602006000500005>
27. 2009) Antioxidant enzymes and lipid peroxidation in endometrium of patients with polyps, myoma, hyperplasia and adenocarcinoma. Reprod. Biol. Endocrin. 7, 149.
< , S., Todorović, A., Stojiljković, V., Kasapović, J., Pajović, S. B. (https://doi.org/10.1186/1477-7827-7-149>
28. 2004) ROS stress in cancer cells and therapeutic implications. Drug Resist. Updat. 7, 97-110.
< , H., Carney, D., Huang, P. (https://doi.org/10.1016/j.drup.2004.01.004>
29. 2004) Prevention of cancers of the breast, endometrium and ovary. Oncogene 23, 6379-6391.
< , M. C., Pearce, C. L., Wu, A. H. (https://doi.org/10.1038/sj.onc.1207899>
30. 2011) Pregnancy history and risk of endometrial cancer. Epidemiology 22, 638-645.
< , G., Doherty, J. A., Voigt, L. F., Beresford, S. A., Hill, D. A., Chen, C., Rossing, M. A., Holmes, R. S., Noor, Z. S., Weiss, N. S. (https://doi.org/10.1097/EDE.0b013e3182263018>
31. 2004) Trophoblast oxidative stress, antioxidants and pregnancy outcome – a review. Placenta 25(Suppl A), S72–S78.
< , L., Raijmakers, M. T. (https://doi.org/10.1016/j.placenta.2004.01.003>
32. 2003) Epidemiology of endometrial cancer. Rev. Gynaecol. Pract. 3, 217-220.
< , D. M. (https://doi.org/10.1016/S1471-7697(03)00020-0>
33. 2002) Risk factors for endometrial hyperplasia: results from a case-control study. Int. J. Gynecol. Cancer 12, 257-260.
< , E., Moroni, S., Parazzini, F., Surace, M., Benzi, G., Salerio, B., Polverino, G., La Vecchia, C. (https://doi.org/10.1136/ijgc-00009577-200205000-00004>
34. 2011) Gynecological conditions and the risk of endometrial cancer. Gynecol. Oncol. 123, 537-541.
< , I. J., Nagle, C. M., Spurdle, A. B., Webb, P. M., Australian National Endometrial Cancer Study Group, Australian Ovarian Cancer Study Group (https://doi.org/10.1016/j.ygyno.2011.08.022>
35. 2006) Endometrial polyps in reproductive-age fertile and infertile women. IMAJ J. 8, 192-195.
, T., Saphier, O., van Voorhis, B. I., Plosker, S. M. (
36. 2005) Risk factors for young premenopausal women with endometrial cancer. Obstet. Gynecol. 105, 575-580.
< , P. T., Oh, J. C., Schmeler, K. M., Sun, C. C., Slomovitz, B. M., Gershenson, D. M., Burke, T. W., Lu, K. H. (https://doi.org/10.1097/01.AOG.0000154151.14516.f7>
37. Straughn, J. M. Jr., Partridge, E. E. (2009) Endometrial cancer. In: General Surgery, Principles and International Practice, eds. Bland, K. I., Sarr, M. G., Büchler, M. W., Csendes, A., Garden, O. J., Wong, J., pp. 1761-1771. Springer-Verlag, London Ltd.
38. 2006) Novel aspects of oxidative stress-associated carcinogenesis. Antioxid. Redox Signal. 8, 1373-1377.
< , S. (https://doi.org/10.1089/ars.2006.8.1373>
39. 2006) Weight change and risk of endometrial cancer. Int. J. Epidemiol. 35, 151-158.
< , A., Nichols, H. B., Hampton, J. M., Newcomb, P. A. (https://doi.org/10.1093/ije/dyi226>
40. 2004) Menstrual and reproductive factors and endometrial cancer risk: results from a population-based case-control study in urban Shanghai. Int. J. Cancer 108, 613-619.
< , W. H., Xiang, Y. B., Ruan, Z. X., Zoeng, W., Cheng, J. R., Dai, Q., Gao, Y. T., Shu, X.O. (https://doi.org/10.1002/ijc.11598>
41. 2000) Prognostic factors in young women with endometrial carcinoma: a report of 20 cases and review of literature. Int. J. Gynecol. Cancer 10, 212-222.
< , K., Seki, K., Matsui, H., Kihara, M., Sekiya, S. (https://doi.org/10.1046/j.1525-1438.2000.010003212.x>
42. 2009) Hormone-related factors and gynecological conditions in relation to endometrial cancer risk. Eur. J. Cancer Prev. 18, 316-321.
< , A., Serraino, D., Polesel, J., Negri, E., De Paoli, A., Dal Maso, L., Montella, M., La Vecchia, C., Franceshi, S., Talamini, R. (https://doi.org/10.1097/CEJ.0b013e328329d830>